Tablon, Elena D.
HRN: 28-68-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/11/2026
03/18/2026
IV
4.5G
Q6
ARF SEC TO CAP HR
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: